Bausch Health cut to hold by Jefferies over B+L update
Jefferies has downgraded Bausch Health (NYSE:BHC) to hold from buy, citing news that a possible sale of its Bausch+Lomb (NYSE:BLCO) unit to a private equity group has fallen through. "While ownership ...
Eli Lilly Stock Rises After Profit, Outlook Top Expectations
Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 ...
Hosted on MSN16h
Arm Holdings Stock Edges Lower Despite Q3 Earnings Beat, Wave Of Price Target Hikes: Retail Stays Extremely Bullish
Arm Holdings Plc. (NASDAQ: ARM) stock fell 3.7% after the chip designer’s earnings outlook for the current quarter was in ...
Jefferies Keeps Their Buy Rating on Broadcom (AVGO)
In a report released yesterday, Blayne Curtis from Jefferies reiterated a Buy rating on Broadcom (AVGO – Research Report). The company’s shares ...
Jefferies Sticks to Its Hold Rating for REA Group Ltd (RPGRF)
In a report released today, Roger Samuel from Jefferies maintained a Hold rating on REA Group Ltd (RPGRF – Research Report), with a price ...
The Financial Express19h
JB Pharma is riding the CDMO Opportunity. Jefferies reiterates buy…
Jefferies maintains a Buy rating on JB Pharma citing strong CDMO growth potential and a 34% upside. Know more about it.
Jarden poaches from Jefferies for new head of financials research
Wilson will be based in Melbourne and joins Jarden after its equity capital markets team ended 2024 on the No.5 spot on the ...